SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-008130
Filing Date
2022-05-06
Accepted
2022-05-06 16:06:44
Documents
72
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q fmtx-20220331.htm   iXBRL 10-Q 2392466
2 EX-31.1 fmtx-ex31_1.htm EX-31.1 12561
3 EX-31.2 fmtx-ex31_2.htm EX-31.2 12752
4 EX-32.1 fmtx-ex32_1.htm EX-32.1 9921
  Complete submission text file 0000950170-22-008130.txt   8595307

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT fmtx-20220331_pre.xml EX-101.PRE 401111
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT fmtx-20220331.xsd EX-101.SCH 74488
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT fmtx-20220331_def.xml EX-101.DEF 228530
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT fmtx-20220331_cal.xml EX-101.CAL 52845
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT fmtx-20220331_lab.xml EX-101.LAB 517297
66 EXTRACTED XBRL INSTANCE DOCUMENT fmtx-20220331_htm.xml XML 1558711
Mailing Address 300 NORTH BEACON STREET SUITE 501 WATERTOWN MA 02472
Business Address 300 NORTH BEACON STREET SUITE 501 WATERTOWN MA 02472 617-679-1970
Forma Therapeutics Holdings, Inc. (Filer) CIK: 0001538927 (see all company filings)

IRS No.: 371657129 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39333 | Film No.: 22901056
SIC: 2836 Biological Products, (No Diagnostic Substances)